JUN 07, 2021 4:00 PM BST

Alinity m STI* with extragenital samples: from assay design to real world experience

Speakers

Abstract

DATE: June 7, 2021

TIME:  4:00pm BST

 

The World Health Organization (WHO) estimates that more than 1 million individuals contract a sexually transmitted infection (STI) every day. The most common STI pathogens are Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV). Urogenital infections due to these pathogens can lead to severe consequences in reproductive health and increase the risk of acquiring or transmitting HIV-1 while the extragenital CT and NG infections in the oropharynx and rectum in men and women can serve as a reservoir potentially resulting in future infections and may also lead to severe clinical complications.  Accurate and rapid diagnosis of sexually transmitted infections (STIs) is essential for timely administration of appropriate treatment and reducing the spread of the disease.   This webinar will discuss design and development of Alinity m STI* assay including performance characteristics of Alinity m STI* assay (CT/NG) with extragenital sample types.  

 

Learning objectives:

  • Understand the differences and similarities in clinical manifestation of CT, NG, TV and MG.
  • Learn about the design and development of the Alinity m STI* assay.
  • Learn about performance characteristics of the Alinity m STI* assay (CT/NG) with extragenital sample types.

 

 

*Alinity m STI assay is CE marked and is not commercially available in the U.S.

 

Webinars will be available for unlimited on-demand viewing after live event.


Show Resources
You May Also Like
OCT 13, 2022 9:00 AM +08
OCT 13, 2022 9:00 AM +08
First Broadcast: Date: October 12, 2022 Time: 8:00am PDT, 11:00am EDT Second Broadcast: Date: October 12, 2022 Time: 9:00am SGT The new Embedded CryoSPARC Live, now fully integrated with t...
AUG 10, 2022 10:00 AM PDT
AUG 10, 2022 10:00 AM PDT
Date: August 10, 2022 Time: 10:00am PDT, 1:00pm EDT The global pandemic has increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provid...
SEP 28, 2022 9:00 AM PDT
SEP 28, 2022 9:00 AM PDT
Date: September 28, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) While COVID-19 continues to be the most pressing diagnostic focus for clinical laboratories, HIV remains a serious g...
NOV 16, 2022 7:00 PM PST
C.E. CREDITS
NOV 16, 2022 7:00 PM PST
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
C.E. CREDITS
Date: October 25, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CEST) Candida auris is a multi-drug resistant yeast that continues to be a global threat for infection and transmission in h...
JUN 29, 2022 8:00 AM PDT
JUN 29, 2022 8:00 AM PDT
Date: June 29, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) As of May 2022, there have been more than 500 million confirmed cases of COVID-19, including numerous variants. Additiona...
Loading Comments...
Show Resources